TASIGNA (nilotinib hydrochloride) Novartis Patent: 7,169,791 Expiration: Jan 4, 2024 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or…
The post Dr…
Drug Patent Expirations for the Week of December 31, 2023 Read Post »
This chart shows the pharmaceutical companies with the most patents in South Africa. Patents must be filed in each country (or, in some cases regional patent office) where patent protection…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in South Africa? Read Post »
This chart shows the pharmaceutical companies with the most patents in Singapore. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug pa…
Which pharmaceutical companies have the most drug patents in Singapore? Read Post »
Annual Drug Patent Expirations for VICTOZA Victoza is a drug marketed by Novo Nordisk Inc and is included in one NDA. It is available from two suppliers. There are six…
The post New patent expiration for Novo Nordisk drug VICTOZA appeared first on Drug…
New patent expiration for Novo Nordisk drug VICTOZA Read Post »
Annual Drug Patent Expirations for CHLORAPREP+ONE-STEP Chloraprep One-step is a drug marketed by Becton Dickinson Co and is included in two NDAs. It is available from two suppliers. There are…
The post New patent expiration for Becton Dickinson drug CH…
New patent expiration for Becton Dickinson drug CHLORAPREP ONE-STEP Read Post »
Annual Drug Patent Expirations for CHLORAPREP+WITH+TINT Chloraprep With Tint is a drug marketed by Becton Dickinson Co and is included in one NDA. It is available from two suppliers. There…
The post New patent expiration for Becton Dickinson drug CHLOR…
New patent expiration for Becton Dickinson drug CHLORAPREP WITH TINT Read Post »
Annual Drug Patent Expirations for SAXENDA Saxenda is a drug marketed by Novo and is included in one NDA. It is available from one supplier. There are twenty-one patents protecting…
The post New patent expiration for NOVO drug SAXENDA appeared first on…
This chart shows the pharmaceutical companies with the most gel dosed drugs. For a different perspective, see the most popular dosage types. The companies with the most gel dosed drugs…
The post Which pharmaceutical companies have the most gel dosed dr…
Which pharmaceutical companies have the most gel dosed drugs? Read Post »
Annual Drug Patent Expirations for HEPZATO Hepzato is a drug marketed by Delcath Systems Inc and is included in one NDA. It is available from one supplier. There are nine…
The post New patent for Delcath Systems drug HEPZATO appeared first on DrugPaten…
Annual Drug Patent Expirations for NOCDURNA Nocdurna is a drug marketed by Ferring Pharms Inc and is included in one NDA. It is available from one supplier. There are ten…
The post New patent expiration for Ferring Pharms drug NOCDURNA appeared first o…
New patent expiration for Ferring Pharms drug NOCDURNA Read Post »
Get new actionable insights and updates from BiotechBlog
